site stats

Impact factor arthritis res ther

WitrynaImpact Factor. Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor? WitrynaArthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals, publishes original …

IJMS Free Full-Text Hypoxia-Inducible Factor-2 Alpha Regulates …

Witryna5 mar 2014 · Arthritis Res Ther. 2014 Mar 5;16(2):R61. doi: 10.1186/ar4498. ... association between pack-years of cigarette smoking and rheumatoid arthritis were included in a dose-response random-effects meta-regression analysis. Results: ... Risk Factors Smoking / adverse effects* ... Witryna10 lut 2024 · Etanercept is an antagonist of tumor necrosis factor alpha (TNFα) which has potent antiinflammatory activity and is used widely in severe forms of rheumatoid arthritis and psoriasis. Etanercept has been linked to rare instances of acute, clinically apparent liver injury. list of us postage stamps https://spumabali.com

Arthritis Research & Therapy Home page

Witryna《arthritis research & therapy》发布于爱科学网,并永久归类相关sci期刊导航类别中,本站只是硬性分析 "《arthritis res ther》" 杂志的可信度。学术期刊真正的价值在 … Witryna27 mar 2024 · Arthritis Res Ther. 2008; 10 (3) R59. ... The effects of tumour necrosis factor inhibitors, methotrexate, nonsteroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015; 74 (3):480–489. WitrynaARTHRITIS RESEARCH & THERAPY. 出版年份:2003 年文章数:260 投稿命中率:50.0%. 出版周期:Bimonthly 自引率:4.5% 审稿周期:平均4.71月. 前往期刊查询. 期刊讨论 中国SCI论文 期刊主页 投稿经验 杂志官网 投稿链接 作者需知 PMC链接 Pubmed全文检索. 期刊论坛. 期刊 ... list of us postal service holidays

ARTHRITIS RESEARCH & THERAPY-期刊论坛,投稿经验 …

Category:Arthritis Research and Therapy - Academic Accelerator

Tags:Impact factor arthritis res ther

Impact factor arthritis res ther

A rheumatoid factor paradox: inhibition of rituximab effector …

WitrynaLiczba wierszy: 13 · Arthritis Research & Therapy Impact Factor, IF, number of article, … Witryna29 sie 2024 · Background: Granulocyte-macrophage colony-stimulating factor (GM-CSF) has emerged as a crucial cytokine that activates myeloid cells to initiate tissue inflammation. However, the molecular actions of GM-CSF against innate immunity are still poorly characterized. Here, we investigated the in vitro effects of GM-CSF on the …

Impact factor arthritis res ther

Did you know?

Witryna13 kwi 2024 · Ozoralizumab (OZR), a tumor necrosis factor alpha (TNFα) inhibitor, is a NANOBODY® compound that binds to TNFα and human serum albumin. The main objective of this study was to analyze the pharmacokinetics (PK) of the drug and its correlation with clinical efficacy in patients with rheumatoid arthritis (RA). Efficacy … Witryna23 mar 2024 · Prognostic factors are used for treatment decisions in rheumatoid arthritis (RA). High disease activity, the early presence of erosions, and autoantibody …

Witryna13 kwi 2024 · Rheumatoid arthritis (RA) is a chronic inflammatory joint disease affecting around 0.5 to 1.0% of the adult population [].Therapeutic drugs against RA include synthetic and biological disease-modifying anti-rheumatic drugs (DMARDs), and glucocorticoids [].Despite available treatment options, a significant proportion of … Witryna23 mar 2024 · Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies …

WitrynaCitation Impact 8.823 - 2-year Impact Factor (2024) 9.037 - 5-year Impact Factor (2024) 1.657 - Source Normalized Impact per Paper (SNIP) 2.802 - SCImago Journal … WitrynaArthritis Care & Research. Journal Abbreviation: ARTHRIT CARE RES. Journal ISSN: 2151-464X. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) …

Witryna12 maj 2010 · A skewed ratio of pro-inflammatory to anti-inflammatory cytokines, elevated growth factor synthesis and T- and B-lymphocyte activation are 3 hallmarks of rheumatoid arthritis (RA) pathology. Interleukin-6 (IL-6), IL-7, IL-17, IL-12/IL-23 and growth factors, granulocyte macrophage-colony stimulating factor, IL-3, and …

Witryna14 wrz 2024 · Objectives: To investigate the incidence of pneumocystis pneumonia (PCP) and its risk factors in patients with rheumatic disease receiving non-high-dose … immotherm serviceportalWitrynaAlzheimers Research & Therapy. Journal Abbreviation: ALZHEIMERS RES THER. Journal ISSN: 1758-9193. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) 8.823. immo theouleWitryna8 lis 2024 · Background and Objectives: The aim of the study was to evaluate body composition (BC) of rheumatoid arthritis (RA) patients at disease onset compared to population controls focusing on the associations between low lean mass and disease specific parameters, nutritional factors and physical activity. Materials and Methods: … immo therapyWitryna13 kwi 2024 · 《Stem Cell Research & Therapy》发布于爱科学网,并永久归类相关SCI期刊导航类别中,本站只是硬性分析 "《STEM CELL RES THER》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。 immotherm ht agWitryna19 lip 2024 · Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. ... the impact of a high BMI on the response to tumor necrosis factor inhibitors (TNFi) has only been formally demonstrated for infliximab in two retrospective ... Arthritis Res Ther. 2016; 18:71. doi: 10.1186/s13075-016-0969-2. … list of us presidents and first ladiesWitrynaThe Journal of Orthopaedic Research®, a publication of the Orthopaedic Research Society (ORS), is the forum for the rapid publication of high quality reports of new information on the full spectrum of orthopaedic research, including life sciences, engineering, translational, and clinical studies. Announcement of JOR Special Issue - … list of us overseas territoriesWitryna22 gru 2024 · Background: To evaluate the effects of tumor necrosis factor inhibitors (TNFi), interleukin-6 receptor inhibitors (IL-6Ri), and Janus kinase inhibitors (JAKi) on … immothep meylan